Juvenile Idiopathic Arthritis

• FDA label_change · 2024-10-10
  FDA Approved: SOVUNA — Supplemental Application (ANI Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for SOVUNA (hydroxychloroquine sulfate) by ANI Pharmaceuticals, Inc., indicating a label change.

• FDA label_change · 2019-12-26
  FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)

  FDA approved a supplemental application for OTREXUP (methotrexate) from Antares Pharma, Inc., leading to changes in the labeling for this su…

• FDA label_change · 2016-09-13
  FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.)

  FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.) indicating a labeling modification related to celecoxib.